EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic immune dysregulation and neutrophil activation define prognostic inflammatory signatures in drug-resistant epilepsy

Coraly Simoës Da Gama, Aurélie Hanin, Gwen Goudard, Véronique Masson, Aurore Besnard, Karim Dorgham, Guy Gorochov, Guillaume Dorothée, Valerio Frazzini, Vincent Navarro, Mélanie Morin-Brureau

JCI Insight · 22.05.2026 · 11 (10)

DOI: 10.1172/jci.insight.200419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 14.04.2026. Verfasst von Coraly Simoës Da Gama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Hôpital Saint-Antoine, Paris, France. Hauptthemen laut MEDLINE: Neutrophils, Neutrophil Activation, Inflammation, Drug Resistant Epilepsy. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANR, ANR Investissements d’avenir, Fondation Assistance Publique-Hôpitaux de Paris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic inflammation is now recognized as a key contributor to epilepsy pathophysiology, yet the role of innate immune cells, particularly neutrophils, remains poorly defined in epilepsy. Preclinical studies in rodent models have implicated neutrophils in seizure activity, but their phenotype in human epilepsy has not been thoroughly investigated. In this study, we aimed to characterize systemic inflammatory profiles and neutrophil-associated immune signatures in the blood of patients with drug-resistant epilepsy compared with healthy controls. We identified a systemic low-grade inflammatory profile in patients characterized by elevated neutrophil-to-lymphocyte ratio, C-reactive protein, proinflammatory cytokines (IL-6, CXCL8/IL-8, TNF-α), and activated neutrophils (CXCR4 + CD62L lo ). Neutrophil phenotyping revealed two distinct immune profiles. Patients with longer disease duration exhibited a more immature systemic signature characterized by immature neutrophils (CD15 + CD10 – ), resting neutrophils (CXCR4 + CD62L + ), and elevated IL-6 levels. In contrast, patients with higher seizure frequency displayed a more inflammatory profile, marked by increased IL-12 and activated (CXCR4 + CD62L lo ) and hyperactivated (CXCR4 hi CD62L lo ) neutrophil subsets. Moreover, elevated presurgical levels of inflammatory profile TNF-α, IL-6, and hyperactivated CXCR4 hi CD62L lo neutrophils were associated with seizure recurrence 1 year after surgery. This pioneering study highlights the heterogeneity of peripheral immune responses in drug-resistant epilepsy and identifies neutrophil-related signatures as promising prognostic biomarkers in this context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsNeutrophil ActivationInflammationDrug Resistant EpilepsyHumansFemaleMaleAdultPrognosisCytokinesAdolescentYoung AdultReceptors, CXCR4

Stichwörter der Autor:innen

EpilepsyImmunologyInflammationNeuroscienceNeutrophils

Substanzen

CytokinesReceptors, CXCR4

Autor:innen und Institutionen

  • Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Hôpital Saint-Antoine, Paris, France.
  • Sorbonne Université, Paris Brain Institute, ICM, INSERM, CNRS, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • AP-HP, Sorbonne Université, Pitié-Salpêtrière - Charles Foix University Hospital, Department of Metabolic Biochemistry, DMU BioGeMH, Paris, France.
  • Université Paris Cité, Faculté de Pharmacie, Paris, France.
  • AP-HP, Epilepsy Unit, Pitié-Salpêtrière Hospital, Paris, France.
  • Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses, AP-HP, Département d'Immunologie, Hôpital de la Pitié-Salpêtrière, Paris, France.

Förderung

  • ANR
  • ANR Investissements d’avenir
  • Fondation Assistance Publique-Hôpitaux de Paris

Zitieren

APA

Simoës Da Gama, C., Hanin, A., Goudard, G., Masson, V., Besnard, A., Dorgham, K., Gorochov, G., Dorothée, G., Frazzini, V., Navarro, V., & Morin-Brureau, M. (2026). Systemic immune dysregulation and neutrophil activation define prognostic inflammatory signatures in drug-resistant epilepsy. JCI Insight, 11(10). https://doi.org/10.1172/jci.insight.200419

Vancouver

Simoës Da Gama C, Hanin A, Goudard G, Masson V, Besnard A, Dorgham K, et al. Systemic immune dysregulation and neutrophil activation define prognostic inflammatory signatures in drug-resistant epilepsy. JCI Insight. 2026;11(10). doi:10.1172/jci.insight.200419

BibTeX
@article{SimosDaGama2026,
  author = {Simoës Da Gama, Coraly and Hanin, Aurélie and Goudard, Gwen and Masson, Véronique and Besnard, Aurore and Dorgham, Karim and Gorochov, Guy and Dorothée, Guillaume and Frazzini, Valerio and Navarro, Vincent and Morin-Brureau, Mélanie},
  title = {Systemic immune dysregulation and neutrophil activation define prognostic inflammatory signatures in drug-resistant epilepsy},
  journal = {JCI Insight},
  year = {2026},
  volume = {11},
  number = {10},
  doi = {10.1172/jci.insight.200419}
}
Kostenlos starten →